Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
announced it has launched Eptifibatide for Injection in the United States as a therapeutic equivalent generic for Integrilin ® for Injection (Eptifibatide) approved by the U.S. Food and Drug Administration. Eptifibatide for Injection is indicated for use in acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Avenacy's Eptifibatide for Injection is available as a 75 mg/100 mL single-dose vial. In line with Avenacy's mission to champion patient safety and streamline patient care, Eptifibatide for Injection will feature the Company's highly differentiated packaging and labeling to support accurate medication selection. Avenacy will begin shipping Eptifibatide for Injection to wholesale partners this week. The Company is supported by a global network of development and FDA-approved cGMP-certified contract manufacturing partners. Eptifibatide for Injection had U.S. sales of approximately $8.3 million for the twelve months ending in June 2023. Approved Indica
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Leading Penang-based Healthcare Provider Bags Multiple Awards at the GlobalHealth Asia-Pacific Awards 2024 [Yahoo! Finance Canada]Yahoo! Finance Canada
- U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute [Yahoo! Finance]Yahoo! Finance
- Avenacy Announces Launch of Magnesium Sulfate in Water for Injection in the U.S. Market [Yahoo! Finance]Yahoo! Finance
- U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA InstituteBusiness Wire
- BIO Asia-Taiwan 2024 opens July 24th [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 5/2/24 - Beat
IQV
Sec Filings
- 5/10/24 - Form 8-K
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- IQV's page on the SEC website